Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Balance Sheets

v3.22.1
Unaudited Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 122,216 $ 109,618
Other receivables - related party 32 50
Prepaid expenses and other current assets 1,905 2,038
Total current assets 124,153 111,706
Property, plant and equipment, net 8,468 9,025
Fixed assets - construction in process 2,043 2,027
Restricted cash 1,000 1,000
Other assets 286 362
Operating lease right-of-use asset, net 1,011 1,050
Total Assets 136,961 125,170
Current Liabilities:    
Accounts payable and accrued expenses 9,615 9,744
Payables and accrued expenses - related party 811 723
Operating lease liabilities - short-term 358 348
Total current liabilities 10,784 10,815
Deferred income 270 270
Note payable, long-term (net of discount of $4,064 and nil as of March 31, 2022 and December 31, respectively) 26,986 0
Operating lease liabilities - long-term 1,590 1,685
Total Liabilities 39,630 12,770
Commitments and Contingencies (Note 11)
Stockholders' Equity    
Preferred stock ($0.0001 par value), 2,000,000 shares authorized, 250,000 shares of Class A preferred stock issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 0 0
Common stock issuable, 27,393 and 2,536,607 shares as of March 31, 2022 and December 31, 2021, respectively 27 4,329
Additional paid-in capital 368,933 359,906
Accumulated deficit (271,639) (251,844)
Total Stockholders' Equity 97,331 112,400
Total Liabilities and Stockholders' Equity 136,961 125,170
Class A Common Shares [Member]    
Stockholders' Equity    
Common Stock ($0.0001 par value), 150,000,000 and 125,000,000 shares authorized as of March 31, 2022 and December 31, 2021, respectively 0 0
Common Shares [Member]    
Stockholders' Equity    
Common Stock ($0.0001 par value), 150,000,000 and 125,000,000 shares authorized as of March 31, 2022 and December 31, 2021, respectively $ 10 $ 9